Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion

NuklearMedizin

Volumn 35, Issue 4, 1996, Pages 122-125

  Wafelman, Amon R ^a,b,c   Hoefnagel, Cornelis A ^b   Maes, Robert A A ^d   Beijnen, Jos H ^a,b,d  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

infusion concentrates; radiochemical purity; radiochemical stability; 131I iodide; 131I MIBG

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131;

ARTICLE; CONTROLLED STUDY; DRUG PURITY; RADIOCHEMISTRY;

EID: 0029745549     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629825     Document Type: Article

References (8)

1. Hoefnagel CA. Radionuclide therapy revisited. Eur J Nucl Med 1991; 18: 408-31.
2. 131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis (»MIBG de novo«). J Nucl Biol Med 1991; 35: 248-51.
3. Murray IPC, Ell PJ. Nuclear medicine in clinical diagnosis and treatment. ISBN 0-443-04710-3, London: Churchill Livingstone, 1994.
4. 131I]Metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 1991; 35: 269-76.
5. Wafelman AR, Hoefnagel CA, Maes RAA, Beijnen JH. A comparison of the radiochemical stability of different iodine-131 labelled metaiodobenzylguanidine formulations for therapeutic use. Appl Radiat Isot 1994; 45: 183-9.
6. Wafelman AR, Suchi R, Hoefnagel CA, Beijnen JH. Radiochemical purity of iodine-131 labelled metaiodobenzylguanidine infusion fluids: a report from clinical practice. Eur J Nucl Med 1993; 20: 614-6.
7. 131I]MIBG infusion fluids: a comparison and discussion of the chromatographic characteristics using three different techniques. Appl Radiat Isot 1993; 44: 859-67.
8. 131I-labelled metaiodobenzylguanidine for therapeutic use. Nucl Med Commun 1993; 14: 819-22.